Healthcare & Medical

Cancer Genomics Consortium (CGC) Annual Meeting 2026

Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. Sequence short to ultra-long DNA/RNA fragments, for a streamlined and rapid solution to comprehensively characterise cancer and tumour research samples: from SNVs to epigenetic alterations and large-scale structural ab…

Visit the official site
2Speakers
1Sponsors
1Exhibitors
0Sessions
2Companies · in total

Speakers

Programmed at Cancer, in alphabetical order.

Cate Randall Paschal
PhD, FACMG, CGC 2026 Program Committee Chair · Cancer Genomics Consortium
Cate Randall Paschal, PhD, FACMG
Program Committee Chair · Cancer Genomics Consortium

Sponsors

The companies behind the program. Tiers as disclosed.

Oxford Nanopore Technologies
Company intelligence

What does it mean when 2 companies show up, and 1 bet on three roles at once?

Two companies. one are betting more than once.

The numbers below are derived from the speakers, sponsors, and exhibitors on this page, cross-referenced into one ledger. They are the only thing here that 10times.com cannot tell you.

Who's in the room
1All threespeak · spons · exh
0Sponsoringsponsor only
0Exhibitingexhibitor only
1Speakingspeaker only

In all three roles

Oxford Nanopore Technologies

Speakers by seniority
  • Other roles2100%

Of 2 speakers · classified by free-text title

Most-represented companies
#CompanyRolesSpeakers
1Oxford Nanopore TechnologiesSponsorExhibitor-
2Cancer Genomics Consortium2
Sponsors by tier
unspecified1
100% of 1